Cargando…
COVID-19 long haulers
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277229/ https://www.ncbi.nlm.nih.gov/pubmed/34257426 http://dx.doi.org/10.1038/s41587-021-00984-7 |